PTK6 and colorectal carcinoma: In our study, we found that targeting PTK6 using XMU-MP-2 remarkably attenuated the stemness and increased the chemotherapy sensitivity of CRC in both nude mice and PDX models, indicating XMU-MP-2 could dramatically enhance the sensitivity of chemotherapy in CRC.